Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study

Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: An open-labeled pilot study.BackgroundTacrolimus is a relatively new calcineurin inhibitor that has been increasingly used in transplant medicine. The objective of the current work is to report our preliminary experience with tacrolimus in the treatment of diffuse proliferative glomerulonephritis in systemic lupus erythematosus (SLE).MethodsNine consecutive patients who...